Medikabazaar, a B2B healthcare supply chain platform, has reported a strong start to FY27, posting 57% year-on-year growth in the first quarter with revenue of Rs. 592 crore.

The growth is driven by robust performance across its digital business, medical devices, pharmaceuticals, healthcare exports, strategic key accounts, and technology-enabled procurement solutions.

Building on the momentum of FY26, the company has reaffirmed its target of achieving a Rs. 3,000 crore topline in FY27, representing around 45% growth over the previous financial year. 

The company is also targeting a 15-fold increase in EBITDA, reflecting its focus on profitable growth, operational efficiency, and long-term value creation.

Dinesh Lodha, Managing Director & Group CEO, Medikabazaar, said the company's Q1 results demonstrate the strength of its growth strategy and disciplined execution across business verticals. "We have built a business that balances rapid growth with sustainable profitability while creating long-term value for customers, partners and investors.”

“More importantly, we are creating an ecosystem that enables Indian healthcare manufacturers to scale faster across domestic and international markets. This gives us strong confidence in achieving our FY27 ambition of Rs. 3,000 crore topline with significantly enhanced profitability," Lodha added.

A key pillar of Medikabazaar's strategy is the development of a 360-degree growth ecosystem for Indian healthcare manufacturers. 

The company is building an integrated go-to-market platform that enables manufacturers to expand their presence across domestic and international markets, going beyond conventional distribution services.

As part of this strategy, Medikabazaar plans to establish more than 100 strategic OEM partnerships, including several exclusive commercial alliances, providing manufacturers with an end-to-end commercial platform to accelerate business growth in India and overseas.